Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis

Background: Rheumatoid arthritis (RA) is a genetically complex disease where the response to different treatments varies greatly between different patients. This is the case with the tumour necrosis factor (TNF) blocking agents, where 20–40% of patients have been described as non-responders. No pred...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Padyukov, L, Lampa, J, Heimburger, M, Ernestam, S, Cederholm, T, Lundkvist, I, Andersson, P, Hermansson, Y, Harju, A, Klareskog, L, Bratt, J
Médium: Artigo
Jazyk:Inglês
Vydáno: 2003
Témata:
Extended Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1754569/
https://ncbi.nlm.nih.gov/pubmed/12759288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.62.6.526
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky